PD51-05 FEASIBILITY OF OMITTING CT PELVIS IN PATIENTS WITH STAGE I GERM CELL TUMOR (GCT) ON ACTIVE SURVEILLANCE: A MULTI-INSTITUTIONAL STUDY. (May 2022)